Related references
Note: Only part of the references are listed.Antidepressant-like effects of β-caryophyllene on restraint plus stress-induced depression
Eun-Sang Hwang et al.
BEHAVIOURAL BRAIN RESEARCH (2020)
Dual pharmacological inhibitor of endocannabinoid degrading enzymes reduces depressive-like behavior in female rats
Bin Dong et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2020)
Neuropeptide Y and cannabinoids interaction in the amygdala after exposure to shock and reminders model of PTSD
Neta Maymon et al.
NEUROPHARMACOLOGY (2020)
Sex differences in psychiatric disorders: what we can learn from sex chromosome aneuploidies
Tamar Green et al.
NEUROPSYCHOPHARMACOLOGY (2019)
Familial abnormalities of endocannabinoid signaling in schizophrenia
Dagmar Koethe et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2019)
Caffeine and cannabinoid receptors modulate impulsive behavior in an animal model of attentional deficit and hyperactivity disorder
Douglas T. Leffa et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2019)
Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats
Alice Hartmann et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Anxiolytic and antidepressant effects of ACPA and harmaline co-treatment
Mohaddeseh Ebrahimi-Ghiri et al.
BEHAVIOURAL BRAIN RESEARCH (2019)
Ketamine-induced antidepressant like effects in mice: A possible involvement of cannabinoid system
Fatemeh Khakpai et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Serum Endocannabinoid and Mood Changes after Exercise in Major Depressive Disorder
Jacob D. Meyer et al.
MEDICINE & SCIENCE IN SPORTS & EXERCISE (2019)
Hemisphere-dependent endocannabinoid system activity in prefrontal cortex and hippocampus of the Flinders Sensitive Line rodent model of depression
C. Kirkedal et al.
NEUROCHEMISTRY INTERNATIONAL (2019)
Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants
Pablo Romero-Sanchiz et al.
NEUROPHARMACOLOGY (2019)
Effects of Different Stressors Are Modulated by Different Neurobiological Systems: The Role of GABA-A Versus CB1 Receptor Gene Variants in Anxiety and Depression
Xenia Gonda et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Bipolar disorder and the endocannabinoid system
Shokouh Arjmand et al.
ACTA NEUROPSYCHIATRICA (2019)
Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development
Thuy Nguyen et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2019)
Endocannabinoid system imbalance in the postmortem prefrontal cortex of subjects with schizophrenia
Carolina Muguruza et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Cannabinoid CB1 receptors mediate the anxiolytic effects induced by systemic alprazolam and intra-periaqueductal gray 5-HT1A receptor activation
Luara A. Batista et al.
NEUROSCIENCE LETTERS (2019)
Repetitive high-frequency transcranial magnetic stimulation reverses depressive-like behaviors and protein expression at hippocampal synapses in chronic unpredictable stress-treated rats by enhancing endocannabinoid signaling
Shan-shan Xue et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2019)
In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis
Faith Borgan et al.
JAMA PSYCHIATRY (2019)
NMDAR Hypofunction Animal Models of Schizophrenia
Gloria Lee et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Association of CNR1 genotypes with changes in neurocognitive performance after eighteen-month treatment in patients with first-episode psychosis
Martina Rojnic Kuzman et al.
EUROPEAN PSYCHIATRY (2019)
Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa
Roberto Collu et al.
INTERNATIONAL JOURNAL OF EATING DISORDERS (2019)
Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit
Valeria Almeida et al.
NEUROPHARMACOLOGY (2019)
Association of Genetic Liability to Psychotic Experiences With Neuropsychotic Disorders and Traits
Sophie E. Legge et al.
JAMA PSYCHIATRY (2019)
A functional variant of CB2 receptor gene interacts with childhood trauma and FAAH gene on anxious and depressive phenotypes
Judit Lazary et al.
JOURNAL OF AFFECTIVE DISORDERS (2019)
Phenolic compounds from nutmeg (Myristica fragrans Houtt.) inhibit the endocannabinoid-modulating enzyme fatty acid amide hydrolase
Abir T. El-Alfy et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2019)
The association of endocannabinoid receptor genes (CNR1 and CNR2) polymorphisms with depression A meta-analysis
Xiangjuan Kong et al.
MEDICINE (2019)
Schizophrenia
Stephen R. Marder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Disruption of an enhancer associated with addictive behaviour within the cannabinoid receptor-1 gene suggests a possible role in alcohol intake, cannabinoid response and anxiety-related behaviour
Elizabeth A. Hay et al.
PSYCHONEUROENDOCRINOLOGY (2019)
Impact of FAAH genetic variation on fronto-amygdala function during emotional processing
Anne Gaertner et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2019)
Upregulation of Anandamide Hydrolysis in the Basolateral Complex of Amygdala Reduces Fear Memory Expression and Indices of Stress and Anxiety
Maria Morena et al.
JOURNAL OF NEUROSCIENCE (2019)
Cannabinoid CB1 receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior
Chen-Jie Shen et al.
NATURE MEDICINE (2019)
Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks
Thercia G. Viana et al.
NEUROPHARMACOLOGY (2019)
Impaired anandamide/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responses
Tina Zimmermann et al.
NEUROPSYCHOPHARMACOLOGY (2019)
Ventral hippocampal overexpression of Cannabinoid Receptor Interacting Protein 1 (CNRIP1) produces a schizophrenia-like phenotype in the rat
Stephanie M. Perez et al.
SCHIZOPHRENIA RESEARCH (2019)
FAAH genotype, CRFR1 genotype, and cortisol interact to predict anxiety in an aging, rural Hispanic population: A Project FRONTIER study
Breanna N. Harris et al.
NEUROBIOLOGY OF STRESS (2019)
CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity
Arnau Busquets-Garcia et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective
Ziva D. Cooper et al.
NEUROPSYCHOPHARMACOLOGY (2018)
The endocannabinoid system in mental disorders: Evidence from human brain studies
Ines Ibarra-Lecue et al.
BIOCHEMICAL PHARMACOLOGY (2018)
The Lateral Habenula Directs Coping Styles Under Conditions of Stress via Recruitment of the Endocannabinoid System
Anthony L. Berger et al.
BIOLOGICAL PSYCHIATRY (2018)
Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD
Sharon Fidelman et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2018)
Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
Shenglong Zou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Enhanced endocannabinoid tone as a potential target of pharmacotherapy
Marek Toczek et al.
LIFE SCIENCES (2018)
Regulation of noradrenergic and serotonergic systems by cannabinoids: relevance to cannabinoid-induced effects
Aitziber Mendiguren et al.
LIFE SCIENCES (2018)
Effects of rTMS on Hippocampal Endocannabinoids and Depressive-like Behaviors in Adolescent Rats
Guoxiang Fang et al.
NEUROCHEMICAL RESEARCH (2018)
Impaired glucocorticoid-mediated HPA axis negative feedback induced by juvenile social isolation in male rats
Giorgia Boero et al.
NEUROPHARMACOLOGY (2018)
Role of endocannabinoids in the hippocampus and amygdala in emotional memory and plasticity
Amir Segev et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2
Sabrina Francesca Lisboa et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Alterations in Gene and Protein Expression of Cannabinoid CB2 and GPR55 Receptors in the Dorsolateral Prefrontal Cortex of Suicide Victims
Maria S. Garcia-Gutierrez et al.
NEUROTHERAPEUTICS (2018)
Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors
Gaurav Bedse et al.
TRANSLATIONAL PSYCHIATRY (2018)
Sex-specific effects of CB1 receptor antagonism and stress in adolescence on anxiety, corticosterone concentrations, and contextual fear in adulthood in rats
Jonathan J. Simone et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2018)
Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety
Andalib Danandeh et al.
PSYCHOPHARMACOLOGY (2018)
Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia
Felipe V. Gomes et al.
SCHIZOPHRENIA RESEARCH (2018)
The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents
Guy Griebel et al.
SCIENTIFIC REPORTS (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Spencer L. G. James et al.
LANCET (2018)
Anatomical Characterization of the Cannabinoid CB1 Receptor in Cell-Type-Specific Mutant Mouse Rescue Models
Ana Gutierrez-Rodriguez et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2017)
Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study
Laura Kranaster et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2017)
The effects of enhancing endocannabinoid signaling and blocking corticotrophin releasing factor receptor in the amygdala and hippocampus on the consolidation of a stressful event
Nurit Aisenberg et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)
Comparative analysis of MBD-seq and MeDIP-seq and estimation of gene expression changes in a rodent model of schizophrenia
Jennifer L. Neary et al.
GENOMICS (2017)
Cannabinoid receptors on peripheral leukocytes from patients with schizophrenia: Evidence for defective immunomodulatory mechanisms
Salvina Maria de Campos-Carli et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2017)
Fatty acid amide hydrolase inhibitors produce rapid anti-anxiety responses through amygdala long-term depression in male rodents
Tingting Duan et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2017)
2-Arachidonoylglycerol endocannabinoid signaling coupled to metabotropic glutamate receptor type-5 modulates anxiety-like behavior in the rat ventromedial prefrontal cortex
Ana F. Almeida-Santos et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
The effects of cannabinoid receptors activation and glucocorticoid receptors deactivation in the amygdala and hippocampus on the consolidation of a traumatic event
Noa Shoshan et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2017)
The CB1 Receptor as the Cornerstone of Exostasis
Pier Vincenzo Piazza et al.
NEURON (2017)
Chronic stress leads to epigenetic dysregulation in the neuropeptide-Y and cannabinoid CB1 receptor genes in the mouse cingulate cortex
Ermelinda Lomazzo et al.
NEUROPHARMACOLOGY (2017)
ANXIOUS BEHAVIOR INDUCES ELEVATED HIPPOCAMPAL Cb2 RECEPTOR GENE EXPRESSION
James M. Robertson et al.
NEUROSCIENCE (2017)
ROLE OF BETA-CATENIN AND ENDOCANNABINOIDS IN THE NUCLEUS ACCUMBENS IN EXTINCTION IN RATS EXPOSED TO SHOCK AND REMINDERS
Nachshon Korem et al.
NEUROSCIENCE (2017)
DISTINCT ROLES OF NEURONAL AND MICROGLIAL CB2 CANNABINOID RECEPTORS IN THE MOUSE HIPPOCAMPUS
Yong Li et al.
NEUROSCIENCE (2017)
The Impact of CB2 Receptor Ligands on the MK-801-Induced Hyperactivity in Mice
Marta Kruk-Slomka et al.
NEUROTOXICITY RESEARCH (2017)
Changes in the cannabinoids receptors in rats following treatment with antidepressants
Irena Smaga et al.
NEUROTOXICOLOGY (2017)
A behavioral and pharmacological characterization of palatable diet alternation in mice
Catherine F. Moore et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2017)
Chemical probes to potently and selectively inhibit endocannabinoid cellular reuptake
Andrea Chicca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Endocannabinoid dysregulation in cognitive and stress-related brain regions in the Nrg1 mouse model of schizophrenia
David J. Clarke et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2017)
A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia
Claudio D'Addario et al.
SCHIZOPHRENIA RESEARCH (2017)
Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors
Sagnik Bhattacharyya et al.
SCIENTIFIC REPORTS (2017)
Selectively Impaired Endocannabinoid-Dependent Long-Term Depression in the Lateral Habenula in an Animal Model of Depression
Hoyong Park et al.
CELL REPORTS (2017)
Schizophrenia and depression, two poles of endocannabinoid system deregulation
Maria Rodriguez-Munoz et al.
TRANSLATIONAL PSYCHIATRY (2017)
Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference
Qing-Rong Liu et al.
SCIENTIFIC REPORTS (2017)
Addressing sufficiency of the CB1 receptor for endocannabinoid-mediated functions through conditional genetic rescue in forebrain GABAergic neurons
Floortje Remmers et al.
BRAIN STRUCTURE & FUNCTION (2017)
Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the Modulation of Anxiety
Gaurav Bedse et al.
BIOLOGICAL PSYCHIATRY (2017)
FAAH inhibition produces antidepressant-like efforts of mice to acute stress via synaptic long-term depression
Ying Wang et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
Activation of cannabinoid receptors elicits antidepressant-like effects in a mouse model of social isolation stress
Arvin Haj-Mirzaian et al.
BRAIN RESEARCH BULLETIN (2017)
Brain cannabinoid receptor 2: expression, function and modulation
De-Jie Chen et al.
ACTA PHARMACOLOGICA SINICA (2017)
Interaction Between the Cannabinoid and Vanilloid Systems on Anxiety in Male Rats
Nafiseh Faraji et al.
BASIC AND CLINICAL NEUROSCIENCE (2017)
The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys
John Fayyad et al.
ADHD-ATTENTION DEFICIT AND HYPERACTIVITY DISORDERS (2017)
Impaired 2-AG Signaling in Hippocampal Glutamatergic Neurons: Aggravation of Anxiety-Like Behavior and Unaltered Seizure Susceptibility
Stephan Guggenhuber et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Schizophrenia-Like Phenotype Inherited by the F2 Generation of a Gestational Disruption Model of Schizophrenia
Stephanie M. Perez et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Neurobiological Interactions Between Stress and the Endocannabinoid System
Maria Morena et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Sex-dependence of anxiety-like behavior in cannabinoid receptor 1 (Cnr1) knockout mice
Mallory E. Bowers et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Reduced Brain Cannabinoid Receptor Availability in Schizophrenia
Mohini Ranganathan et al.
BIOLOGICAL PSYCHIATRY (2016)
Interactions Between Anandamide and Corticotropin-Releasing Factor Signaling Modulate Human Amygdala Function and Risk for Anxiety Disorders: An Imaging Genetics Strategy for Modeling Molecular Interactions
Catherine H. Demers et al.
BIOLOGICAL PSYCHIATRY (2016)
Positron Emission Tomography Studies on Cannabinoid Receptor Type 1 in Schizophrenia
Yoan Mihov
BIOLOGICAL PSYCHIATRY (2016)
Human Laboratory Studies on Cannabinoids and Psychosis
Mohamed Sherif et al.
BIOLOGICAL PSYCHIATRY (2016)
Anxiety, Stress, and Fear Response in Mice With Reduced Endocannabinoid Levels
Imke Jenniches et al.
BIOLOGICAL PSYCHIATRY (2016)
Role of hypothalamic cannabinoid receptors in post-stroke depression in rats
Shanshan Wang et al.
BRAIN RESEARCH BULLETIN (2016)
Involvement of opioid system in antidepressant-like effect of the cannabinoid CB1 receptor inverse agonist AM-251 after physical stress in mice
Sattar Ostadhadi et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2016)
Role of the endocannabinoid 2-arachidonoylglycerol in aversive responses mediated by the dorsolateral periaqueductal grey
P. H. Gobira et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma
Judit Lazary et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Targeting the Endocannabinoid System in Psychiatric Illness
Martin A. Katzman et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)
Heterologous regulation of the cannabinoid type 1 receptor by angiotensin II in astrocytes of spontaneously hypertensive rats
Dhanush Haspula et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Acute Stress Suppresses Synaptic Inhibition and Increases Anxiety via Endocannabinoid Release in the Basolateral Amygdala
Shi Di et al.
JOURNAL OF NEUROSCIENCE (2016)
Dysregulated peripheral endocannabinoid system signaling is associated with cognitive deficits in first-episode psychosis
Miguel Bioque et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2016)
Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety
Maria Morena et al.
NEUROPHARMACOLOGY (2016)
Decreased CB receptor binding and cannabinoid signaling in three brain regions of a rat model of schizophrenia
Edina Szucs et al.
NEUROSCIENCE LETTERS (2016)
The Influence of the CB1 Receptor Ligands on the Schizophrenia-Like Effects in Mice Induced by MK-801
Marta Kruk-Slomka et al.
NEUROTOXICITY RESEARCH (2016)
The endocannabinoid system and Post Traumatic Stress Disorder (PTSD): From preclinical findings to innovative therapeutic approaches in clinical settings
Andrea Berardi et al.
PHARMACOLOGICAL RESEARCH (2016)
Putative Epigenetic Involvement of the Endocannabinoid System in Anxiety- and Depression-Related Behaviors Caused by Nicotine as a Stressor
Tamaki Hayase
PLOS ONE (2016)
Individual differences in frontolimbic circuitry and anxiety emerge with adolescent changes in endocannabinoid signaling across species
Dylan G. Gee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Characterization of peripheral cannabinoid receptor expression and clinical correlates in schizophrenia
Kayla A. Chase et al.
PSYCHIATRY RESEARCH (2016)
Endocannabinoid concentrations in hair are associated with PTSD symptom severity
Sarah Wilker et al.
PSYCHONEUROENDOCRINOLOGY (2016)
Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function
J. Megan Gray et al.
PSYCHONEUROENDOCRINOLOGY (2016)
Endocannabinoid-Mediated Plasticity in Nucleus Accumbens Controls Vulnerability to Anxiety after Social Defeat Stress
Clementine Bosch-Bouju et al.
CELL REPORTS (2016)
Molecular mechanisms involved in the side effects of fatty acid amide hydrolase inhibitors: a structural phenomics approach to proteome-wide cellular off-target deconvolution and disease association
Shihab Dider et al.
NPJ SYSTEMS BIOLOGY AND APPLICATIONS (2016)
The endocannabinoid, endovanilloid and nitrergic systems could interact in the rat dorsolateral periaqueductal gray matter to control anxiety-like behaviors
Priscila A. Batista et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: Mechanism of action and possible interactions with cholinergic system
Marta Kruk-Slomka et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Lack of Hypophagia in CB1 Null Mice is Associated to Decreased Hypothalamic POMC and CART Expression
Ricardo Lage et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think Tank
Elizabeth Scarr et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
The rs1049353 Polymorphism in the CNR1 Gene Interacts With Childhood Abuse to Predict Posttraumatic Threat Symptoms
Natalie Mota et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB1R signaling and anxiety-like behavior
Roberta Imperatore et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Corticotropin-Releasing Hormone Drives Anandamide Hydrolysis in the Amygdala to Promote Anxiety
J. Megan Gray et al.
JOURNAL OF NEUROSCIENCE (2015)
Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses
Luara A. Batista et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
The endocannabinoid system in guarding against fear, anxiety and stress
Beat Lutz et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Endocannabinoid signalling and the deteriorating brain
Vincenzo Di Marzo et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Potential Therapeutic Value of a Novel FAAH Inhibitor for the Treatment of Anxiety
Eva M. Marco et al.
PLOS ONE (2015)
Cannabinoid CBI receptors in the dorsal hippocampus and prelimbic medial prefrontal cortex modulate anxiety-like behavior in rats: Additional evidence
Sabrina F. Lisboa et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2015)
Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms
Paula Suarez-Pinilla et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2015)
The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study
Rakesh Jetly et al.
PSYCHONEUROENDOCRINOLOGY (2015)
FAAH genetic variation enhances fronto-amygdala function in mouse and human
Iva Dincheva et al.
NATURE COMMUNICATIONS (2015)
Cannabinoid type-1 receptor signaling in central serotonergic neurons regulates anxiety-like behavior and sociability
Martin Häring et al.
Frontiers in Behavioral Neuroscience (2015)
Blockade of 2-Arachidonoylglycerol Hydrolysis Produces Antidepressant-Like Effects and Enhances Adult Hippocampal Neurogenesis and Synaptic Plasticity
Zhen Zhang et al.
HIPPOCAMPUS (2015)
Role of CNR1 polymorphisms in moderating the effects of psychosocial adversity on impulsivity in adolescents
Arlette F. Buchmann et al.
JOURNAL OF NEURAL TRANSMISSION (2015)
Interaction between the Cholecystokinin and Endogenous Cannabinoid Systems in Cued Fear Expression and Extinction Retention
Mallory E. Bowers et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Dissociable Deficits of Executive Function Caused by Gestational Adversity are Linked to Specific Transcriptional Changes in the Prefrontal Cortex
Nicola M. Grissom et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats
Thercia G. Viana et al.
PSYCHOPHARMACOLOGY (2015)
A Cannabinoid Receptor 1 Polymorphism Is Protective Against Major Depressive Disorder in Methadone-Maintained Outpatients
Romain Icick et al.
AMERICAN JOURNAL ON ADDICTIONS (2015)
Psychiatric Disorders: Diagnosis to Therapy
John H. Krystal et al.
CELL (2014)
Preliminary, Open-Label, Pilot Study of Add-On Oral Δ9-Tetrahydrocannabinol in Chronic Post-Traumatic Stress Disorder
Pablo Roitman et al.
CLINICAL DRUG INVESTIGATION (2014)
Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report
Mateus M. Bergamaschi et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2014)
Use of a Synthetic Cannabinoid in a Correctional Population for Posttraumatic Stress Disorder-Related Insomnia and Nightmares, Chronic Pain, Harm Reduction, and Other Indications A Retrospective Evaluation
Colin Cameron et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2014)
Relationships between serotonergic and cannabinoid system in depressive-like behavior: a PET study with [11C]-DASB
Aurelijus Burokas et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Anti-depressive mechanism of repetitive transcranial magnetic stimulation in rat: The role of the endocannabinoid system
Hua-ning Wang et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2014)
Endocannabinoids, Related Compounds and Their Metabolic Routes
Filomena Fezza et al.
MOLECULES (2014)
Cannabinoid modulation of prefrontal-limbic activation during fear extinction learning and recall in humans
Christine A. Rabinak et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2014)
Cannabinoid Receptor Activation Prevents the Effects of Chronic Mild Stress on Emotional Learning and LTP in a Rat Model of Depression
Amir Segev et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Cannabinoids Prevent the Effects of a Footshock Followed by Situational Reminders on Emotional Processing
Nachshon Korem et al.
NEUROPSYCHOPHARMACOLOGY (2014)
PERIPHERAL AND INTRA-DORSOLATERAL STRIATUM INJECTIONS OF THE CANNABINOID RECEPTOR AGONIST WIN 55,212-2 IMPAIR CONSOLIDATION OF STIMULUS-RESPONSE MEMORY
J. Goodman et al.
NEUROSCIENCE (2014)
Antidepressants and Changes in Concentration of Endocannabinoids and N-Acylethanolamines in Rat Brain Structures
Irena Smaga et al.
NEUROTOXICITY RESEARCH (2014)
β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice
Amine Bahi et al.
PHYSIOLOGY & BEHAVIOR (2014)
The microinjection of a cannabinoid agonist into the accumbens shell induces anxiogenesis in the elevated plus-maze
Larissa Kochenborger et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice
Hai-Ying Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population
Joon Seol Bae et al.
PSYCHIATRIC GENETICS (2014)
CB2 receptor agonism reverses MK-801-induced disruptions of prepulse inhibition in mice
Ramy Khella et al.
PSYCHOPHARMACOLOGY (2014)
Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia
David W. Volk et al.
SCHIZOPHRENIA RESEARCH (2014)
Cognitive performance and peripheral endocannabinoid system receptor expression in schizophrenia
Rodrigo Ferretjans et al.
SCHIZOPHRENIA RESEARCH (2014)
Genetic Disruption of 2-Arachidonoylglycerol Synthesis Reveals a Key Role for Endocannabinoid Signaling in Anxiety Modulation
Brian C. Shonesy et al.
CELL REPORTS (2014)
Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation
R. J. Bluett et al.
TRANSLATIONAL PSYCHIATRY (2014)
Consequences of early life stress on the expression of endocannabinoid-related genes in the rat brain
Eva M. Marco et al.
BEHAVIOURAL PHARMACOLOGY (2014)
The Endocannabinoid System and the Brain
Raphael Mechoulam et al.
ANNUAL REVIEW OF PSYCHOLOGY, VOL 64 (2013)
Cannabinoid type 1 receptor ligands WIN 55,212-2 and AM 251 alter anxiety-like behaviors of marmoset monkeys in an open-field test
Priscila Cagni et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray
A. F. Almeida-Santos et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia
Marta Costa et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
CB1 receptor signaling regulates social anxiety and memory
Y. Litvin et al.
GENES BRAIN AND BEHAVIOR (2013)
Monoacylglycerol lipase inhibition-induced changes in plasma corticosterone levels, anxiety and locomotor activity in male CD1 mice
Mano Aliczki et al.
HORMONES AND BEHAVIOR (2013)
CNR1 Gene and Risk of the Metabolic Syndrome in Patients With Schizophrenia
Weiping Yu et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
Association of Single-Nucleotide Polymorphisms in the Cannabinoid Receptor 2 Gene with Schizophrenia in the Han Chinese Population
Dongxiao Tong et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2013)
Cannabinoid modulation of chronic mild stress-induced selective enhancement of trace fear conditioning in adolescent rats
Christian G. Reich et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure
M. N. Hill et al.
MOLECULAR PSYCHIATRY (2013)
Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity
O. Gunduz-Cinar et al.
MOLECULAR PSYCHIATRY (2013)
Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study
A. Neumeister et al.
MOLECULAR PSYCHIATRY (2013)
Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia
Jenny Ceccarini et al.
NEUROIMAGE (2013)
Cannabinoid facilitation of fear extinction memory recall in humans
Christine A. Rabinak et al.
NEUROPHARMACOLOGY (2013)
Peripheral Endocannabinoid System Dysregulation in First-Episode Psychosis
Miquel Bioque et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Predator threat stress promotes long lasting anxiety-like behaviors and modulates synaptophysin and CB1 receptors expression in brain areas associated with PTSD symptoms
Alline Cristina Campos et al.
NEUROSCIENCE LETTERS (2013)
Tolerance to hypophagia induced by prolonged treatment with a CB1 antagonist is related to the reversion of anorexigenic neuropeptide gene expression in the hypothalamus
Rodrigo Rorato et al.
REGULATORY PEPTIDES (2013)
No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample
Claudia Pisanu et al.
PSYCHIATRY RESEARCH (2013)
Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks
Matthew N. Hill et al.
PSYCHONEUROENDOCRINOLOGY (2013)
Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit
Eti Ganon-Elazar et al.
PSYCHONEUROENDOCRINOLOGY (2013)
Endocannabinoid metabolism in the prefrontal cortex in schizophrenia
David W. Volk et al.
SCHIZOPHRENIA RESEARCH (2013)
Quantification of endocannabinoids in postmortem brain of schizophrenic subjects
Carolina Muguruza et al.
SCHIZOPHRENIA RESEARCH (2013)
Neuregulin 1: a prime candidate for research into gene-environment interactions in schizophrenia? Insights from genetic rodent models
Tim Karl
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2013)
Multiple Functions of Endocannabinoid Signaling in the Brain
Istvan Katona et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 35 (2012)
Cannabinoid Receptor Genotype Moderation of the Effects of Childhood Physical Abuse on Anhedonia and Depression
Arpana Agrawal et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Expression pattern of the cannabinoid receptor genes in the frontal cortex of mood disorder patients and mice selectively bred for high and low fear
Kwang Choi et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2012)
The role of the endocannabinoid system in the neuroendocrine regulation of energy balance
Francisco Javier Bermudez-Silva et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes
Marina Mitjans et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Effects of amphetamine on dopamine release in the rat nucleus accumbens shell region depend on cannabinoid CB1 receptor activation
J. Kleijn et al.
NEUROCHEMISTRY INTERNATIONAL (2012)
The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior
Manoela V. Fogaca et al.
NEUROPHARMACOLOGY (2012)
Cannabinoids Prevent the Development of Behavioral and Endocrine Alterations in a Rat Model of Intense Stress
Eti Ganon-Elazar et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Biphasic Effects of Cannabinoids in Anxiety Responses: CB1 and GABAB Receptors in the Balance of GABAergic and Glutamatergic Neurotransmission
Alejandro Aparisi Rey et al.
NEUROPSYCHOPHARMACOLOGY (2012)
CBI RECEPTOR-DEFICIENT MICE AS A MODEL FOR DEPRESSION
O. Valverde et al.
NEUROSCIENCE (2012)
Dysfunction in Fatty Acid Amide Hydrolase Is Associated with Depressive-Like Behavior in Wistar Kyoto Rats
K. Yaragudri Vinod et al.
PLOS ONE (2012)
Antidepressant-like effects of Δ9-tetrahydrocannabinol and rimonabant in the olfactory bulbectomised rat model of depression
Maha M. ElBatsh et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
The CNR1 gene in depression and schizophrenia - Is there an association with early improvement and response?
Rebecca Schennach et al.
PSYCHIATRY RESEARCH (2012)
Lower levels of cannabinoid 1 receptor mRNA in female eating disorder patients: Association with wrist cutting as impulsive self-injurious behavior
Marc Schroeder et al.
PSYCHONEUROENDOCRINOLOGY (2012)
Intense exercise increases circulating endocannabinoid and BDNF levels in humans-Possible implications for reward and depression
E. Heyman et al.
PSYCHONEUROENDOCRINOLOGY (2012)
Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia
Kimberly J. Jenko et al.
SCHIZOPHRENIA RESEARCH (2012)
Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the “Mirror Effect” of Schizophrenia
Joëlle Desfossés et al.
Frontiers in Psychiatry (2012)
Endocannabinoid system dysfunction in mood and related disorders
C. H. Ashton et al.
ACTA PSYCHIATRICA SCANDINAVICA (2011)
Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice
Sudhir N. Umathe et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Brain Type 1 Cannabinoid Receptor Availability in Patients with Anorexia and Bulimia Nervosa
Nathalie Gerard et al.
BIOLOGICAL PSYCHIATRY (2011)
Differential Role of Anandamide and 2-Arachidonoylglycerol in Memory and Anxiety-like Responses
Arnau Busquets-Garcia et al.
BIOLOGICAL PSYCHIATRY (2011)
Genes differentially expressed in CB1 knockout mice: Involvement in the depressive-like phenotype
Ester Aso et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2011)
Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine
Cinzia Guidali et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor
D. Minocci et al.
JOURNAL OF AFFECTIVE DISORDERS (2011)
Decreased GABA(A) and GABA(B) receptor functional activity in cannabinoid CB1 receptor knockout mice
Leyre Urigueen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Anxiolytic-like effect induced by the cannabinoid CB1 receptor agonist, arachydonilcyclopropylamide (ACPA), in the rat amygdala is mediated through the D1 and D2 dopaminergic systems
Mohammad Reza Zarrindast et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice
Maria S. Garcia-Gutierrez et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats
N. Realini et al.
NEUROPHARMACOLOGY (2011)
Paranoid Schizophrenia is Characterized by Increased CB1 Receptor Binding in the Dorsolateral Prefrontal Cortex
Victoria S. Dalton et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice
Antonio Ortega-Alvaro et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Cannabinoid receptor expression and phosphorylation are differentially regulated between male and female cerebellum and brain stem after repeated stress: Implication for PTSD and drug abuse
Guoqiang Xing et al.
NEUROSCIENCE LETTERS (2011)
Pre-pregnancy and pregnancy obesity and neurodevelopmental outcomes in offspring: a systematic review
R. J. Van Lieshout et al.
OBESITY REVIEWS (2011)
Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats
Natale R. Sciolino et al.
PHARMACOLOGICAL RESEARCH (2011)
Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay
Steven G. Kinsey et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2011)
AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents
Mark D. Black et al.
PSYCHOPHARMACOLOGY (2011)
Energy balance regulation by endocannabinoids at central and peripheral levels
Carmelo Quarta et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Supply and demand for endocannabinoids
Bradley E. Alger et al.
TRENDS IN NEUROSCIENCES (2011)
Sexually dimorphic effects of cannabinoid compounds on emotion and cognition
Tiziana Rubino et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2011)
Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects
Eva M. Marco et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2011)
Brain Cannabinoid CB2 Receptor in Schizophrenia
Hiroki Ishiguro et al.
BIOLOGICAL PSYCHIATRY (2010)
Depression-resistant endophenotype in mice overexpressing cannabinoid CB2 receptors
M. S. Garcia-Gutierrez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: Comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142
K. S. Sink et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2010)
The endocannabinoid system and psychiatric disorders
Daniela Parolaro et al.
EXPERIMENTAL NEUROLOGY (2010)
Cannabinoids Modulate Hippocampal Memory and Plasticity
Hila Abush et al.
HIPPOCAMPUS (2010)
Loss of Retrograde Endocannabinoid Signaling and Reduced Adult Neurogenesis in Diacylglycerol Lipase Knock-out Mice
Ying Gao et al.
JOURNAL OF NEUROSCIENCE (2010)
The cannabinoid CB1 receptor is involved in the anxiolytic, sedative and amnesic actions of benzodiazepines
Maria S. Garcia-Gutierrez et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Preservation of Striatal Cannabinoid CB1 Receptor Function Correlates with the Antianxiety Effects of Fatty Acid Amide Hydrolase Inhibition
Silvia Rossi et al.
MOLECULAR PHARMACOLOGY (2010)
Depression-like phenotype following chronic CB1 receptor antagonism
Chad E. Beyer et al.
NEUROBIOLOGY OF DISEASE (2010)
Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR
Dean F. Wong et al.
NEUROIMAGE (2010)
The Endocannabinoid 2-Arachidonoylglycerol Produced by Diacylglycerol Lipase α Mediates Retrograde Suppression of Synaptic Transmission
Asami Tanimura et al.
NEURON (2010)
Deficiency in Endocannabinoid Signaling in the Nucleus Accumbens Induced by Chronic Unpredictable Stress
Wei Wang et al.
NEUROPSYCHOPHARMACOLOGY (2010)
FACILITATION OF ENDOCANNABINOID EFFECTS IN THE VENTRAL HIPPOCAMPUS MODULATES ANXIETY-LIKE BEHAVIORS DEPENDING ON PREVIOUS STRESS EXPERIENCE
A. C. Campos et al.
NEUROSCIENCE (2010)
Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression
Palmiero Monteleone et al.
PHARMACOLOGICAL RESEARCH (2010)
A role for 2-arachidonoylglycerol and endocannabinoid signaling in the locomotor response to novelty induced by olfactory bulbectomy
Sarah A. Eisenstein et al.
PHARMACOLOGICAL RESEARCH (2010)
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
R. G. Pertwee et al.
PHARMACOLOGICAL REVIEWS (2010)
Promoter Variants of the Cannabinoid Receptor 1 Gene (CNR1) in Interaction With 5-HTTLPR Affect the Anxious Phenotype
Judit Lazary et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2009)
Modulation of anxiety by acute blockade and genetic deletion of the CB1 cannabinoid receptor in mice together with biogenic amine changes in the forebrain
Gunnar Thiemann et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats
Christian G. Reich et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Prepulse inhibition and genetic mouse models of schizophrenia
Susan B. Powell et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Divergent Effects of Genetic Variation in Endocannabinoid Signaling on Human Threat- and Reward-Related Brain Function
Ahmad R. Hariri et al.
BIOLOGICAL PSYCHIATRY (2009)
Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice
Gernot Riedel et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
The Endocannabinoid System and Pain
Josee Guindon et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
Involvement of hypothalamic peptides in the anorectic action of the CB1 receptor antagonist rimonabant (SR 141716)
Aaron N. A. Verty et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation
Guy A. Cabral et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)
Cannabis and anxiety: a critical review of the evidence
Jose Alexandre Crippa et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2009)
Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia
Daniela Vigano et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2009)
Altered CB1 receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine
Antonio Rodriguez-Gaztelumendi et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Anxiolytic Effects in Mice of a Dual Blocker of Fatty Acid Amide Hydrolase and Transient Receptor Potential Vanilloid Type-1 Channels
Vincenzo Micale et al.
NEUROPSYCHOPHARMACOLOGY (2009)
CNR1 Gene is Associated with High Neuroticism and Low Agreeableness and Interacts with Recent Negative Life Events to Predict Current Depressive Symptoms
Gabriella Juhasz et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Endocannabinoid-Mediated Control of Synaptic Transmission
Masanobu Kano et al.
PHYSIOLOGICAL REVIEWS (2009)
Depression-like behaviour in rats with mononeuropathy is reduced by the CB2-selective agonist GW405833
Bing Hu et al.
PAIN (2009)
Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids
Alline Cristina Campos et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress
Matthew N. Hill et al.
PSYCHONEUROENDOCRINOLOGY (2009)
Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment
Leyre Uriguen et al.
PSYCHOPHARMACOLOGY (2009)
Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats
J. Haller et al.
PSYCHOPHARMACOLOGY (2009)
Association of the Cannabinoid Receptor Gene (CNR1) With ADHD and Post-Traumatic Stress Disorder
Ake T. Lu et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2008)
Functional Expression of Brain Neuronal CB2 Cannabinoid Receptors Are Involved in the Effects of Drugs of Abuse and in Depression
Emmanuel S. Onaivi et al.
DRUG ADDICTION: RESEARCH FRONTIERS AND TREATMENT ADVANCES (2008)
Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia
Stephen M. Eggan et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system
Mohammad-Reza Zarrindast et al.
BEHAVIOURAL PHARMACOLOGY (2008)
Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation:: Relevance to schizophrenia
Mihaly Hajos et al.
BIOLOGICAL PSYCHIATRY (2008)
CB2 receptors in the brain: role in central immune function
G. A. Cabral et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Activation of cannabinoid CB, receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test
Sabrina F. Lisboa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia
Nora Hamdani et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Cannabinoid receptor 1 (CNR1) gene:: Impact on antidepressant treatment response and emotion processing in Major Depression
Katharina Domschke et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents
Matthew N. Hill et al.
JOURNAL OF NEURAL TRANSMISSION (2008)
BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice
Ester Aso et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment
Matthew N. Hill et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy
Stephane Potvin et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour
T. Rubino et al.
NEUROPHARMACOLOGY (2008)
The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition
Maria Scherma et al.
NEUROPHARMACOLOGY (2008)
Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors
Fabricio A. Moreira et al.
NEUROPHARMACOLOGY (2008)
Brain Neuronal CB2 Cannabinoid Receptors in Drug Abuse and Depression: From Mice to Human Subjects
Emmanuel S. Onaivi et al.
PLOS ONE (2008)
Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice
Nima Naderi et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
Serum endocannabinoid content is altered in females with depressive disorders: A preliminary report
M. N. Hill et al.
PHARMACOPSYCHIATRY (2008)
Cat odour-induced anxiety -: a study of the involvement of the endocannabinoid system
Silva Sutt et al.
PSYCHOPHARMACOLOGY (2008)
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials
Robin Christensen et al.
LANCET (2007)
Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress
Marco Bortolato et al.
BIOLOGICAL PSYCHIATRY (2007)
Genotype effects of CHRNA7, CNRI and COMT in schizophrenia:: interactions with tobacco and cannabis use
Stanley Zammit et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
Enhancement of endocannabinoid signaling and the pharmacotherapy of depression
Regina A. Mangleri et al.
PHARMACOLOGICAL RESEARCH (2007)
Cannabinoids elicit antidepressant-like Behavior and activate Serotonergic neurons through the medial prefrontal cortex
Francis Rodriguez Bambico et al.
JOURNAL OF NEUROSCIENCE (2007)
No association of CNR1 gene variations with susceptibility to schizophrenia
Juergen Seifert et al.
NEUROSCIENCE LETTERS (2007)
Cannabinoid receptor antagonists counteract sensorimotor Gating deficits in the phencyclidine model of psychosis
Martina Ballmaier et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Electroconvulsive shock treatment differentially modulates cortical and subcortical endocannabinoid activity
Matthew N. Hill et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Δ9-tetrahydrocannabinol in rats
Tiziana Rubino et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Local enhancement of cannabinoid CB1 receptor signalling in the dorsal hippocampus elicits an antidepressant-like effect
Ryan J. McLaughlin et al.
BEHAVIOURAL PHARMACOLOGY (2007)
Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients:: Impact of cannabis use
F. Markus Leweke et al.
SCHIZOPHRENIA RESEARCH (2007)
Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression
D. Koethe et al.
JOURNAL OF NEURAL TRANSMISSION (2007)
Enrichment of epidermal stem cells by rapid adherence and analysis of the reciprocal interaction of epidermal stem cells with neighboring cells using an organotypic system
Rui Dong et al.
CELL BIOLOGY INTERNATIONAL (2007)
Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task
Stephen A. Varvel et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray
Fabricio Araujo Moreira et al.
NEUROPHARMACOLOGY (2007)
Involvement of the endocannabinoid system in the ability of long-term tricyclic antidepressant treatment to suppress stress-induced activation of the hypothalamic-pituitary-adrenal axis
Matthew N. Hill et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Anxiolytic-like properties of the anandamide transport inhibitor AM404
Marco Bortolato et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia
Kelly A. Newell et al.
EXPERIMENTAL BRAIN RESEARCH (2006)
COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord
Y Yiangou et al.
BMC NEUROLOGY (2006)
Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain
JP Gong et al.
BRAIN RESEARCH (2006)
Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain
Emmanuel S. Onaivi
NEUROPSYCHOBIOLOGY (2006)
Identification and functional characterization of brainstem cannabinoid CB2 receptors
MD Van Sickle et al.
SCIENCE (2005)
Differential response to acute and repeated stress in cannabinoid CB1 receptor knockout newborn and adult mice
E Fride et al.
BEHAVIOURAL PHARMACOLOGY (2005)
Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-naive and plus-maze-experienced mice
RJ Rodgers et al.
BEHAVIOURAL PHARMACOLOGY (2005)
CB1 cannabinoid receptor-mediated modulation of food intake in mice
JL Wiley et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Endocannabinoid system and stress and anxiety responses
MP Viveros et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa
P Monteleone et al.
NEUROPSYCHOPHARMACOLOGY (2005)
A nonsynonymous polymorphism in the human fatty acid amide hydrolase gene did not associate with either methamphetamine dependence or schizophrenia
Y Morita et al.
NEUROSCIENCE LETTERS (2005)
Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear
JP Chhatwal et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents
G Griebel et al.
BIOLOGICAL PSYCHIATRY (2005)
Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1)
FJ Barrero et al.
PHARMACOGENOMICS JOURNAL (2005)
The endocannabinoid system: Physiology and pharmacology
FR de Fonseca et al.
ALCOHOL AND ALCOHOLISM (2005)
Participation of the cannabinoid system in the regulation of emotional-like behaviour
O Valverde
CURRENT PHARMACEUTICAL DESIGN (2005)
A role for cannabinoid CB1 receptors in mood and anxiety disorders
JM Witkin et al.
BEHAVIOURAL PHARMACOLOGY (2005)
Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice
J Haller et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia
K Zavitsanou et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2004)
Unconditioned and conditioned anxiogenic effects of the cannabinoid receptor agonist CP 55,940 in the social interaction test
RF Genn et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2004)
Molecular characterization of a phospholipase D generating anandamide and its congeners
Y Okamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Enhancement of anxiety-like responsiveness to the cannabinoid CB1 receptor agonist HU-210 following chronic stress
MN Hill et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Genetic deletion and pharmacological blockade of CB1 receptors modulates anxiety in the shock-probe burying test
A Degroot et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents
J Haller et al.
BEHAVIOURAL PHARMACOLOGY (2004)
Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors
L Urigüen et al.
NEUROPHARMACOLOGY (2004)
Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms
A Giuffrida et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Role of endocannabinoid system in mental diseases
J Manzanares et al.
NEUROTOXICITY RESEARCH (2004)
The molecular logic of endocannabinoid signalling
D Piomelli
NATURE REVIEWS NEUROSCIENCE (2003)
Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat
RS Martin et al.
PSYCHOPHARMACOLOGY (2003)
Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice
LP Shearman et al.
BEHAVIOURAL PHARMACOLOGY (2003)
Modulation of anxiety through blockade of anandamide hydrolysis
S Kathuria et al.
NATURE MEDICINE (2003)
Comparative analysis of fatty acid amide hydrolase and CB1 cannabinoid receptor expression in the mouse brain: Evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling
M Egertova et al.
NEUROSCIENCE (2003)
Association between cannabinoid receptor gene (CNR1) and childhood attention deficit/hyperactivity disorder in Spanish male alcoholic patients
G Ponce et al.
MOLECULAR PSYCHIATRY (2003)
The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety
J Haller et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Brain monoglyceride lipase participating in endocannabinoid inactivation
TP Dinh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Endocannabinoid hydrolases
N Ueda
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2002)
Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice:: correlation with behaviour
M Maccarrone et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Cannabinoid receptors and their ligands
RG Pertwee et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2002)
Involvement of CB1 cannabinoid receptors in emotional behaviour
M Martin et al.
PSYCHOPHARMACOLOGY (2002)
CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia
H Ujike et al.
MOLECULAR PSYCHIATRY (2002)
Schizophrenia and the cannabinoid receptor type 1 (CB1):: Association study using a single-base polymorphism in coding exon 1
S Leroy et al.
AMERICAN JOURNAL OF MEDICAL GENETICS (2001)
Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters
C Arévalo et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2001)
Endocannabinoids acting at vascular CB, receptors mediate the vasodilated state in advanced liver cirrhosis
S Bátkai et al.
NATURE MEDICINE (2001)
Association study between cannabinoid receptor gene (CNR1) and pathogenesis and psychotic symptoms of mood disorders
SJ Tsai et al.
AMERICAN JOURNAL OF MEDICAL GENETICS (2001)
Control of the cell survival/death decision by cannabinoids
M Guzman et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2001)
Studies on [H-3]CP-55940 binding in the human central nervous system: Regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use
B Dean et al.
NEUROSCIENCE (2001)
Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia
SJ Tsai et al.
PSYCHIATRIC GENETICS (2000)
Share Paper
